<DOC>
	<DOCNO>NCT02215733</DOCNO>
	<brief_summary>The primary objective study ass whether angiotensin blocker ( ARBs ) telmisartan particular , associate increase overall risk four common cancer , namely , lung , colorectal , breast prostate cancer . A secondary objective explore effect separately four cancer combination angiotensin-converting-enzyme-inhibitors ( ACEIs ) .</brief_summary>
	<brief_title>The Use Angiotensin Receptor Blockers Risk Cancer</brief_title>
	<detailed_description />
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<criteria>Patients prescribe antihypertensive agent 01JAN1995 31DEC2008 least two year uptostandard medical history United Kingdom 's General Practice Research Database ( GPRD ) History cancer time prior cohort entry</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>